Site Navigation
Skip to content
Back to MainLineHealth.org
(External)
Toggle Menu
About
Nav item with submenu
Leadership
Our History and Accomplishments
Milestones
Our Location
Endowed Chairs
Catalyst Magazine
Contact Us
Researchers
Nav item with submenu
Our Researchers
Publications
Programs
Nav item with submenu
Cancer Research
Cardiovascular Disease Research
Clinical Research Center
Research for Other Diseases and Conditions
Services
Tech Development
Nav item with submenu
Acapreneurial
Intellectual Property and Other Technology
Biotech Incubator
Lankenau Ventures
Back to MainLineHealth.org
(External)
About
Nav item with submenu
Leadership
Our History and Accomplishments
Milestones
Our Location
Endowed Chairs
Catalyst Magazine
Contact Us
Researchers
Nav item with submenu
Our Researchers
Publications
Programs
Nav item with submenu
Cancer Research
Cardiovascular Disease Research
Clinical Research Center
Research for Other Diseases and Conditions
Services
Tech Development
Nav item with submenu
Acapreneurial
Intellectual Property and Other Technology
Biotech Incubator
Lankenau Ventures
Clinical Trials
Search
What can we help you find?
Search
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Jump to Section
Jump to Section
Find a Provider
Find a Doctor